Early neurodevelopment and psychosis risk: Role of neurohormones and biological sex in modulating genetic, prenatal and sensory processing factors in brain development

Psychosis: Causes, Diagnosis and Treatment

Volumn , Issue , 2012, Pages 45-78

  Walder, Deborah J ^a   Ospina, Luz ^a   Daly, Maureen ^a   Statucka, Marta ^a   Raparia, Eva ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873525520     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (234)

1. T. F. McNeil and E. Cantor-Graae, "Neuromotor markers of risk for schizophrenia.," Australian and New Zealand journal of psychiatry, vol. 34, pp. S86-90, Nov. 2000.
2. E. F. Walker, T. Savoie, and D. Davis, "Neuromotor Precursors of Schizophrenia," Schizophrenia bulletin, vol. 20, no. 3, pp. 441-451, 1994.
3. E. F. Walker and D. Diforio, "Schizophrenia: a neural diathesis-stress model.," Psychological review, vol. 104, no. 4, pp. 667-685, Oct. 1997.
4. E. F. Walker, D. J. Walder, R. Lewine, and R. Loewy, "Sex differences in the origins and premorbid development of schizophrenia," in Psychiatric illness in women: emerging treatments and research, F. Lewis-Hall, T. S. Williams, J. A. Panetta, and J. H. Herrera, Eds. Washington, D.C.: American Psychiatric Publishing, 2002, pp. 193-214.
5. J. M. Goldstein and D. J. Walder, "Sex differences in schizophrenia: the case for developmental origins," in The early course of schizophrenia, T. Sharma and P. Harvey, Eds. New York, NY: Oxford University Press, 2006, pp. 143-173.
6. A. H. Fanous and K. S. Kendler, "Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework.," Molecular psychiatry, vol. 10, no. 1, pp. 6-13, Jan. 2005.
7. T. D. Cannon, I. M. Rosso, C. E. Bearden, L. E. Sanchez, and T. Hadley, "A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia.," Development and psychopathology, vol. 11, no. 3, pp. 467-85, Jan. 1999.
8. J. Kaufman et al., "Social supports and serotonin transporter gene moderate depression in maltreated children.," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 49, pp. 17316-21, Dec. 2004.
9. D. K. Kinney, A. M. Miller, D. J. Crowley, E. Huang, and E. Gerber, "Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana.," Journal of autism and developmental disorders, vol. 38, no. 3, pp. 481-8, Mar. 2008.
10. M. Weinstock, "The long-term behavioural consequences of prenatal stress.," Neuroscience and biobehavioral reviews, vol. 32, no. 6, pp. 1073-86, Aug. 2008.
11. M. Weinstock, "Sex-dependent changes induced by prenatal stress in cortical and hippocampal morphology and behaviour in rats: An update," Stress, vol. 14, no. 6, pp. 604-13, 2011.
12. J. R. Seckl and M. J. Meaney, "Glucocorticoid programming," in Biobehavioral stress response: protective and damaging effects, B. Yehuda and R. McEwen, Eds. New York, NY: New York Academy of Sciences, 2004, pp. 63-84.
13. S. King, A. Mancini-Marïe, A. Brunet, E. Walker, M. J. Meaney, and D. P. Laplante, "Prenatal maternal stress from a natural disaster predicts dermatoglyphic asymmetry in humans.," Development and Psychopathology, vol. 21, pp. 343-353, 2009.
14. E. F. Walker, H. D. Trotman, J. Brasfied, M. Esterberg, and M. Larsen, "Stress hormones, genes and neuronal signaling in adolescence," in The dynamic genome and mental health: The role of genes and environments in youth development, K. S. Kendler, S. R. Jaffee, and D. Romer, Eds. New York, NY: Oxford University Press, 2011, pp. 388-408.
15. D. C. Dolinoy, R. Das, J. R. Weidman, and R. L. Jirtle, "Metastable epialleles, imprinting, and the fetal origins of adult diseases.," Pediatric research, vol. 61, no. 5 Pt 2, p. 30R-37R, May. 2007.
16. H. Hafner, "Gender differences in schizophrenia.," Psychoneuroendocrinology, vol. 28, pp. 17-54, 2003.
17. D. J. Walder, L. J. Seidman, N. Cullen, J. Su, M. T. Tsuang, and J. M. Goldstein, "Sex differences in language dysfunction in schizophrenia," American Journal of Psychiatry, vol. 163, pp. 470-477, 2006.
18. D. J. Walder, L. J. Seidman, N. Makris, M. T. Tsuang, D. N. Kennedy, and J. M. Goldstein, "Neuroanatomic substrates of sex differences in language dysfunction in schizophrenia: a pilot study.," Schizophrenia research, vol. 90, no. 1-3, pp. 295-301, Feb. 2007.
19. D. J. Walder, V. Mittal, H. D. Trotman, a L. McMillan, and E. F. Walker, "Neurocognition and conversion to psychosis in adolescents at high-risk.," Schizophrenia research, vol. 101, no. 1-3, pp. 161-8, Apr. 2008.
20. D. J. Walder, T. L. C. Andersson, A. L. McMillan, S. M. Breedlove, and E. F. Walker, "Sex differences in digit ratio (2D:4D) are disrupted in adolescents with schizotypal personality disorder: altered prenatal gonadal hormone levels as a risk factor.," Schizophrenia research, vol. 86, no. 1-3, pp. 118-22, Sep. 2006.
21. P. E. Meehl, "Schizotaxia, schizotypy, schizophrenia.," American Psychologist, vol. 17, no. 12, pp. 827-838, 1962.
22. D. J. Walder, M. Statucka, M. P. Daly, K. Axen, and M. Haber, "Biological sex and menstrual cycle phase modulation of cortisol levels and psychiatric symptoms in a non-clinical sample of young adults," Psychiatry Research, In Press.
23. D. C. Javitt, "When doors of perception close: bottom-up models of disrupted cognition in schizophrenia.," Annual review of clinical psychology, vol. 5, pp. 249-75, Jan. 2009.
24. R. T. Lacy, C. F. Mactutus, and S. B. Harrod, "Prenatal IV nicotine exposure produces a sex difference in sensorimotor gating of the auditory startle reflex in adult rats.," International journal of developmental neuroscience, vol. 29, no. 2, pp. 153-61, May. 2011.
25. M. L. Schneider, C. F. Moore, and M. M. Adkins, "The effects of prenatal alcohol exposure on behavior: rodent and primate studies.," Neuropsychology Review, vol. 21, pp. 186-203, 2011.
26. K. Good and L. Kopala, "Sex differences in olfactory function," in Smell and the brain: window to the mind, W. Brewer, D. Castle, and C. Pantelis, Eds. Cambridge, UK: Cambridge University Press, 2006, pp. 183-202.
27. P. J. Moberg, R. Agrin, R. E. Gur, R. C. Gur, B. I. Turetsky, and R. L. Doty, "Olfactory dysfunction in schizophrenia: a qualitative and quantitative review.," Neuropsychopharmacology, vol. 21, no. 3, pp. 325-40, Sep. 1999.
28. B. Quednow et al., "The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers," Journal Neuroscience, vol. 31, pp. 6684-6691, 2011.
29. L. C. Kopala, K. P. Good, K. Morrison, A. S. Bassett, M. Alda, and W. G. Honer, "Impaired olfactory identification in relatives of patients with familial schizophrenia.," American Journal Psychiatry, vol. 158, pp. 1286-1290, 2001.
30. A. G. Cardno and I. I. Gottesman, "Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics," American Journal of Medical Genetics, vol. 97, no. 1, pp. 12-17, 2000.
31. P. F. Sullivan, K. S. Kendler, and M. C. Neale, "Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies," Archives of General Psychiatry, vol. 60, no. 12, pp. 1187-1192, Dec. 2003.
32. I. I. Gottesman and J. Shields, "A polygenic theory of schizophrenia," Proceedings of the National Academy of Sciences of the United States of America, vol. 58, no. 1, pp. 199-205, Jul. 1967.
33. W. Y. Wang, B. J. Barratt, D. G. Clayton, and J. A. Todd, "Genome-wide association studies: theoretical and practical concerns," Nature reviews.Genetics, vol. 6, no. 2, pp. 109-118, Feb. 2005.
34. K. Kendler, S. Jaffee, and D. Romer, The dynamic genome and mental health: The role of genes and environments in youth development. New York, NY: Oxford University Press, 2011.
35. N. M. Williams et al., "A systematic genomewide linkage study in 353 sib pairs with schizophrenia," American Journal of Human Genetics, vol. 73, no. 6, pp. 1355-1367, Dec. 2003.
36. B. K. Suarez et al., "Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample," American Journal of Human Genetics, vol. 78, no. 2, pp. 315-333, Feb. 2006.
37. M. J. Owen, N. Craddock, and M. C. O'Donovan, "Schizophrenia: genes at last?," Trends in genetics, vol. 21, no. 9, pp. 518-525, Sep. 2005.
38. M. Y. Ng et al., "Meta-analysis of 32 genome-wide linkage studies of schizophrenia," Molecular psychiatry, vol. 14, no. 8, pp. 774-785, Aug. 2009.
39. C. A. Ross, R. L. Margolis, S. A. Reading, M. Pletnikov, and J. T. Coyle, "Neurobiology of schizophrenia," Neuron, vol. 52, no. 1, pp.
40. P. J. Harrison and A. J. Law, "Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology," Biological psychiatry, vol. 60, no. 2, pp. 132-140, Jul. 2006.
41. G. Corfas, K. Roy, and J. D. Buxbaum, "Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia," Nature neuroscience, vol. 7, no. 6, pp. 575-580, Jun. 2004.
42. R. E. Straub et al., "Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia," American Journal of Human Genetics, vol. 71, no. 2, pp. 337-348, Aug. 2002.
43. T. Numakawa et al., "Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia," Human molecular genetics, vol. 13, no. 21, pp. 2699-2708, Nov. 2004.
44. N. J. Bray et al., "Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression," Human molecular genetics, vol. 14, no. 14, pp. 1947-1954, Jul. 2005.
45. S. D. Detera-Wadleigh and F. J. McMahon, "G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis," Biological psychiatry, vol. 60, no. 2, pp. 106-114, Jul. 2006.
46. W. Hennah, P. Thomson, L. Peltonen, and D. Porteous, "Genes and schizophrenia: beyond schizophrenia: the role of DISC1 in major mental illness," Schizophrenia bulletin, vol. 32, no. 3, pp. 409-416, Jul. 2006.
47. I. H. Consortium et al., "A second generation human haplotype map of over 3.1 million SNPs," Nature, vol. 449, no. 7164, pp. 851-861, Oct. 2007.
48. S. Shifman et al., "Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women," PLoS genetics, vol. 4, no. 2, p. e28, Feb. 2008.
49. T. Lencz et al., "Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia," Molecular psychiatry, vol. 12, no. 6, pp. 572-580, Jun. 2007.
50. M. C. O'Donovan et al., "Identification of loci associated with schizophrenia by genome-wide association and follow-up," Nature genetics, vol. 40, no. 9, pp. 1053-1055, Sep. 2008.
51. K. C. Murphy, L. A. Jones, and M. J. Owen, "High rates of schizophrenia in adults with velo-cardio-facial syndrome," Archives of General Psychiatry, vol. 56, no. 10, pp. 940-945, Oct. 1999.
52. H. C. Mefford et al., "Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes," The New England journal of medicine, vol. 359, no. 16, pp. 1685-1699, Oct. 2008.
53. A. J. Sharp et al., "A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures," Nature genetics, vol. 40, no. 3, pp. 322-328, Mar. 2008.
54. G. Kirov et al., "Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia," Human molecular genetics, vol. 17, no. 3, pp. 458-465, Feb. 2008.
55. A. G. P. Consortium et al., "Mapping autism risk loci using genetic linkage and chromosomal rearrangements," Nature genetics, vol. 39, no. 3, pp. 319-328, Mar. 2007.
56. M. Tsuang, "Schizophrenia: genes and environment," Biological psychiatry, vol. 47, no. 3, pp. 210-220, Feb. 2000.
57. R. Pidsley and J. Mill, "Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research," Biological psychiatry, vol. 69, no. 2, pp. 146-156, Jan. 2011.
58. A. Bird, "DNA methylation patterns and epigenetic memory," Genes and development, vol. 16, no. 1, pp. 6-21, Jan. 2002.
59. P. K. Yang and M. I. Kuroda, "Noncoding RNAs and intranuclear positioning in monoallelic gene expression," Cell, vol. 128, no. 4, pp. 777-786, Feb. 2007.
60. S. Das et al., "Methylation analysis of the fragile X syndrome by PCR," Genetic testing, vol. 1, no. 3, pp. 151-155, 1997.
61. H. M. Abdolmaleky et al., "Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation," American journal of medical genetics. Part B (Neuropsychiatric genetics), vol. 127, no. 1, pp. 51-59, May. 2004.
62. Z. J. Daskalakis, P. B. Fitzgerald, and B. K. Christensen, "The role of cortical inhibition in the pathophysiology and treatment of schizophrenia," Brain Research Reviews, vol. 56, no. 2, pp. 427-442, Dec. 2007.
63. M. Veldic, A. Guidotti, E. Maloku, J. M. Davis, and E. Costa, "In psychosis, cortical interneurons overexpress DNA-methyltransferase 1," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 6, pp. 2152-2157, Feb. 2005.
64. J. H. Gaddum and K. A. Hameed, "Drugs which antagonize 5-hydroxytryptamine," British journal of pharmacology and chemotherapy, vol. 9, no. 2, pp. 240-248, Jun. 1954.
65. O. O. Polesskaya, C. Aston, and B. P. Sokolov, "Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1," Journal of neuroscience research, vol. 83, no. 3, pp. 362-373, Feb. 2006.
66. H. M. Abdolmaleky et al., "Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder," Human molecular genetics, vol. 15, no. 21, pp. 3132-3145, Nov. 2006.
67. F. Angelucci, S. Brene, and A. A. Mathe, "BDNF in schizophrenia, depression and corresponding animal models," Molecular psychiatry, vol. 10, no. 4, pp. 345-352, Apr. 2005.
68. C. S. Weickert et al., "Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia," Molecular psychiatry, vol. 10, no. 7, pp. 637-650, Jul. 2005.
69. J. Mill et al., "Epigenomic profiling reveals DNA-methylation changes associated with major psychosis," American Journal of Human Genetics, vol. 82, no. 3, pp. 696-711, Mar. 2008.
70. K. Fujita et al., "Serum dopamine-beta-hydroxylase in schizophrenic patients," Journal of neurochemistry, vol. 30, no. 6, pp. 1569-1572, Jun. 1978.
71. H. Y. Meltzer, H. W. Cho, B. J. Carroll, and P. Russo, "Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients," Archives of General Psychiatry, vol. 33, no. 5, pp. 585-591, May. 1976.
72. A. F. Wilson, R. C. Elston, R. M. Siervogel, and L. D. Tran, "Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus," American Journal of Human Genetics, vol. 42, no. 1, pp. 160-166, Jan. 1988.
73. J. F. Cubells et al., "Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation," Human genetics, vol. 102, no. 5, pp. 533-540, May. 1998.
74. J. F. Cubells et al., "A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia," Molecular psychiatry, vol. 5, no. 1, pp. 56-63, Jan. 2000.
75. K. Yamamoto et al., "Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study," American journal of medical genetics. Part B (Neuropsychiatric genetics), vol. 117, no. 1, pp. 33-38, Feb. 2003.
76. J. F. Cubells et al., "Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia," Human genetics, vol. 130, no. 5, pp. 635-643, 2011.
77. S. Shifman et al., "A highly significant association between a COMT haplotype and schizophrenia," American Journal of Human Genetics, vol. 71, no. 6, pp. 1296-1302, Dec. 2002.
78. E. C. Tan, S. A. Chong, H. Wang, E. Chew-Ping Lim, and Y. Y. Teo, "Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia," Molecular brain research, vol. 139, no. 2, pp. 212-216, Oct. 2005.
79. X. Chen et al., "Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia," Human molecular genetics, vol. 15, no. 22, pp. 3329-3342, Nov. 2006.
80. R. Magi, C. M. Lindgren, and A. P. Morris, "Meta-analysis of sex-specific genome-wide association studies," Genetic epidemiology, vol. 34, no. 8, pp. 846-853, Dec. 2010.
81. G. Wang et al., "Overexpression of serotonin receptor and transporter mRNA in blood leukocytes of antipsychotic-free and antipsychotic-naïve schizophrenic patients: Gender differences," Schizophrenia Research, vol. 121, no. 1-3, pp. 160-171, 2010.
82. B. R. Godlewska, L. Olajossy-Hilkesberger, J. Limon, and J. Landowski, "Ser9Gly polymorphism of the DRD3 gene is associated with worse premorbid social functioning and an earlier age of onset in female but not male schizophrenic patients," Psychiatry research, vol. 177, no. 1-2, pp. 266-267, May. 2010.
83. D. J. Walder, H. D. Trotman, J. F. Cubells, J. Brasfield, Y.-L. Tang, and E. F. Walker, "Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents.," Psychiatric genetics, vol. 20, no. 4, pp. 166-70, Aug. 2010.
84. M. F. Dallman et al., "Chronic Stress-Induced Effects of Corticosterone on Brain: Direct and Indirect," Annals of the New York Academy of Sciences, vol. 1018, pp. 141-150, 2004.
85. E. F. Walker, D. J. Walder, and F. Reynolds, "Developmental changes in cortisol secretion in normal and at-risk youth.," Development and psychopathology, vol. 13, no. 3, pp. 721-32, Jan. 2001.
86. E. F. Walker, P. A. Brennan, M. Esterberg, J. Brasfield, B. Pearce, and M. T. Compton, "Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth.," Journal of Abnormal Psychology, vol. 119, no. 2, pp. 401-8, 2010.
87. P. Linkowski, A. Van Onderbergen, M. Kerkhofs, D. Bosson, J. Mendlewicz, and E. Van Cauter, "Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock," American Journal of Physiology, vol. 264, no. 2 Pt. 1, pp. 173-181, 1993.
88. J. van Os, M. Hanssen, M. Bak, R. V. Bijl, and W. Vollebergh, "Do Urbanicity and Familial Liability Coparticipate in Causing Psychosis?," American journal of psychiatry, vol. 160, pp. 477-482, 2003.
89. R. H. Yolken and E. F. Torrey, "Viruses, schizophrenia, and bipolar disorder.," Clinical microbiology reviews, vol. 8, no. 1, pp. 131-45, Jan. 1995.
90. E. Susser et al., "Schizophrenia after prenatal famine. Further evidence.," Archives of general psychiatry, vol. 53, no. 1, pp. 25-31, Jan. 1996.
91. M. Cannon, P. B. Jones, and R. M. Murray, "Obstetric Complications and Schizophrenia: Historical and Meta-Analytic Review," American journal of psychiatry, vol. 159, pp. 1080-1092, 2002.
92. C. Dalman, P. Allebeck, J. Cullberg, C. Grunewald, and M. Koster, "Obstetric complications and risk of schizophrenia: a longitudinal study of a national birth cohort," Archives of general psychiatry, vol. 56, pp. 234-240, May. 1999.
93. C. M. Hultman, P. Sparén, N. Takei, R. M. Murray, and S. Cnattingius, "Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study.," British Medical Journal, vol. 318, no. 7181, pp. 421-6, Feb. 1999.
94. K. K. Nicodemus et al., "Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk.," Molecular psychiatry, vol. 13, no. 9, pp. 873-7, Sep. 2008.
95. M. Tramer, "Über die biologische Bedeutung des Geburtsmonates insbesondere für die Psychoseerkrankung. / The biological significance of the birth month, with special reference to psychosis.," Schweizer Archiv für Neurologie und Psychiatrie, vol. 24, pp. 17-24, 1929.
96. E. F. Torrey, J. Miller, R. Rawlings, and R. H. Yolken, "Seasonality of births in schizophrenia and bipolar disorder: a review of the literature.," Schizophrenia research, vol. 28, no. 1, pp. 1-38, Nov. 1997.
97. M. Tochigi, Y. Okazaki, N. Kato, and T. Sasaki, "What causes seasonality of birth in schizophrenia?," Neuroscience Research, vol. 48, no. 1, pp. 1-11, Jan. 2004.
98. S. A. Mednick, R. A. Machon, M. O. Huttunen, and D. Bonett, "Adult Schizophrenia Following Prenatal Exposure to an Influenza Epidemic," Archives of General Psychiatry, vol. 45, no. 2, pp. 189-192, 1988.
99. R. A. Machón et al., "Adult schizotypal personality characteristics and prenatal influenza in a Finnish birth cohort.," Schizophrenia research, vol. 54, no. 1-2, pp. 7-16, Mar. 2002.
100. A. S. Brown et al., "Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study.," Schizophrenia bulletin, vol. 26, no. 2, pp. 287-95, Jan. 2000.
101. A. S. Brown, P. Cohen, S. Greenwald, and E. Susser, "Nonaffective Psychosis After Prenatal Exposure to Rubella," American Journal of Psychiatry, vol. 157, no. 3, pp. 438-443, Mar. 2000.
102. J. Suvisaari, J. Haukka, A. Tanskanen, T. Hovi, and J. Lönnqvist, "Association between prenatal exposure to poliovirus infection and adult schizophrenia.," The American journal of psychiatry, vol. 156, no. 7, pp. 1100-2, Jul. 1999.
103. P. B. Mortensen et al., "A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring.," Schizophrenia research, vol. 122, no. 1-3, pp. 257-63, Sep. 2010.
104. J. L. Moreno et al., "Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT2A and mGlu2 receptors in the adult offspring.," The Journal of neuroscience, vol. 31, no. 5, pp. 1863-72, Feb. 2011.
105. S. J. Short et al., "Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey.," Biological psychiatry, vol. 67, no. 10, pp. 965-73, May. 2010.
106. J. P. Selten, A. S. Brown, K. G. Moons, J. P. Slaets, E. S. Susser, and R. S. Kahn, "Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands.," Schizophrenia research, vol. 38, no. 2-3, pp. 85-91, Aug. 1999.
107. L. M. Ellman et al., "Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.," Schizophrenia research, vol. 121, no. 1-3, pp. 46-54, Aug. 2010.
108. P. Boksa, "Effects of prenatal infection on brain development and behavior: a review of findings from animal models.," Brain, behavior, and immunity, vol. 24, no. 6, pp. 881-97, Aug. 2010.
109. E. S. Susser and S. P. Lin, "Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945.," Archives of general psychiatry, vol. 49, no. 12, pp. 983-8, Dec. 1992.
110. D. St Clair et al., "Rates of Adult Schizophrenia Following of 1959-1961," Journal of the American Medical Association, vol. 294, no. 5, pp. 557-562, 2005.
111. M.-Q. Xu et al., "Prenatal malnutrition and adult schizophrenia: further evidence from the 1959-1961 Chinese famine.," Schizophrenia bulletin, vol. 35, no. 3, pp. 568-76, May. 2009.
112. A. S. Brown and E. S. Susser, "Prenatal nutritional deficiency and risk of adult schizophrenia.," Schizophrenia bulletin, vol. 34, no. 6, pp. 1054-63, Nov. 2008.
113. J. McGrath et al., "Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study.," Schizophrenia research, vol. 67, no. 2-3, pp. 237-45, Apr. 2004.
114. J. J. McGrath, T. H. Burne, F. Féron, A. Mackay-Sim, and D. W. Eyles, "Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update.," Schizophrenia bulletin, vol. 36, no. 6, pp. 1073-8, Nov. 2010.
115. Q. Shen et al., "The role of pro-inflammatory factors in mediating the effects on the fetus of prenatal undernutrition: implications for schizophrenia.," Schizophrenia research, vol. 99, no. 1-3, pp. 48-55, Feb. 2008.
116. M. O. Huttunen and P. Niskanen, "Prenatal loss of father and psychiatric disorders.," Archives of general psychiatry, vol. 35, no. 4, pp. 429-31, Apr. 1978.
117. C. Dalman, S. Wicks, and P. Allebeck, "Prenatal loss of father and subsequent psychosis: a national cohort study," in The International Congress on Schizophrenia Research, 2005.
118. A. S. Khashan et al., "Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events.," Archives of general psychiatry, vol. 65, no. 2, pp. 146-52, Feb. 2008.
119. J. van Os and J. P. Selten, "Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands," The British Journal of Psychiatry, vol. 172, no. 4, pp. 324-326, Apr. 1998.
120. D. Malaspina et al., "Acute maternal stress in pregnancy and schizophrenia in offspring: a cohort prospective study.," BMC psychiatry, vol. 8, p. 71, Jan. 2008.
121. J. P. Selten, Y. van der Graaf, R. van Duursen, C. C. Gispen-de Wied, and R. S. Kahn, "Psychotic illness after prenatal exposure to the 1953 Dutch Flood Disaster.," Schizophrenia research, vol. 35, no. 3, pp. 243-5, Feb. 1999.
122. J. B. Watson, S. A. Mednick, M. Huttunen, and X. Wang, "Prenatal teratogens and the development of adult mental illness.," Development and Psychopathology, vol. 11, no. 3, pp. 457-466, 1999.
123. D. K. Kinney, W. Hyman, C. Greetham, and S. Tramer, "Increased relative risk for schizophrenia and prenatal exposure to a severe tornado (abstract).," Schizophrenia research, vol. 36, no. 1-3, pp. 45-46, 1999.
124. A. Charil, D. P. Laplante, C. Vaillancourt, and S. King, "Prenatal stress and brain development.," Brain research reviews, vol. 65, no. 1, pp. 56-79, Oct. 2010.
125. R. Pascual, D. Ebner, R. Araneda, M. J. Urqueta, and C. Bustamante, "Maternal stress induces long-lasting Purkinje cell developmental impairments in mouse offspring.," European journal of pediatrics, vol. 169, no. 12, pp. 1517-22, Dec. 2010.
126. K. Kleinhaus et al., "Effects of excessive glucocorticoid receptor stimulation during early gestation on psychomotor and social behavior in the rat.," Developmental psychobiology, vol. 52, no. 2, pp. 121-32, Mar. 2010.
127. A. Sacker, D. J. Done, T. J. Crow, and J. Golding, "Antecedents of schizophrenia and affective illness. Obstetric complications," The British Journal of Psychiatry, vol. 166, no. 6, pp. 734-741, Jun. 1995.
128. R. J. Van Lieshout and L. P. Voruganti, "Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms," Journal of Psychiatry and Neuroscience, vol. 33, no. 5, pp. 395-404, 2008.
129. J. M. Hollister, P. Laing, and S. A. Mednick, "Rhesus Incompatibility as a Risk Factor for Schizophrenia in Male Adults," Archives of general psychiatry, vol. 53, no. 1, pp. 19-24, 1996.
130. C. G. S. Palmer et al., "RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility.," American journal of human genetics, vol. 71, no. 6, pp. 1312-9, Dec. 2002.
131. E. A. Lane and G. W. Albee, "Comparative birth weights of schizophrenics and their siblings," Journal of Psychology, vol. 64, pp. 227-231, 1966.
132. G. Wrede, S. A. Mednick, M. O. Huttunen, and C. G. Nilsson, "Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers.," Acta Psychiatrica Scandinavica, vol. 62, no. 4, pp. 369-381, 1980.
133. L. Rifkin, S. Lewis, P. Jones, B. Toone, and R. Murray, "Low birth weight and schizophrenia," The British Journal of Psychiatry, vol. 165, no. 3, pp. 357-362, Sep. 1994.
134. H. Kunugi, S. Nanko, and R. M. Murray, "Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment," The British Journal of Psychiatry, vol. 178, no. 40, p. s25-s29, Apr. 2001.
135. C. Dalman, H. V. Thomas, A. S. David, J. Gentz, G. Lewis, and P. Allebeck, "Signs of asphyxia at birth and risk of schizophrenia: Population-based case-control study," The British Journal of Psychiatry, vol. 179, no. 5, pp. 403-408, Nov. 2001.
136. R. E. Kendell, K. McInneny, E. Jusczak, and M. Bain, "Obstetric complications and schizophrenia: Two case-control studies based on structured obstetric records," The British Journal of Psychiatry, vol. 176, no. 6, pp. 516-522, Jun. 2000.
137. M. Byrne et al., "Labour and delivery complications and schizophrenia: Case--control study using contemporaneous labour ward records," The British Journal of Psychiatry, vol. 176, no. 6, pp. 531-536, Jun. 2000.
138. M. C. Clarke, M. Harley, and M. Cannon, "The role of obstetric events in schizophrenia.," Schizophrenia bulletin, vol. 32, no. 1, pp. 3-8, Jan. 2006.
139. J. R. Geddes et al., "Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis.," Schizophrenia bulletin, vol. 25, no. 3, pp. 413-23, Jan. 1999.
140. T. D. Cannon, I. M. Rosso, J. M. Hollister, C. E. Bearden, L. E. Sanchez, and T. Hadley, "A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia.," Schizophrenia bulletin, vol. 26, no. 2, pp. 351-66, Jan. 2000.
141. P. F. Bolton, M. Murphy, H. Macdonald, B. Whitlock, A. Pickles, and M. Rutter, "Obstetric complications in autism: consequences or causes of the condition?," Journal of the American Academy of Child and Adolescent Psychiatry, vol. 36, no. 2, pp. 272-81, Feb. 1997.
142. L. Burd, R. Severud, J. Kerbeshian, and M. G. Klug, "Prenatal and perinatal risk factors for autism.," Journal of Perinatal Medicine, vol. 27, no. 6, pp. 441-450, 1999.
143. N. Juul-dam, J. Townsend, and E. Courchesne, "Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population," Pediatrics, vol. 107, p. E63, 2001.
144. S. Sprich-Buckminster, J. Biederman, S. Milberger, S. V. Faraone, and B. K. Lehman, "Are perinatal complications relevant to the manifestation of ADD? Issues of comorbidity and familiality.," Journal of the American Academy of Child and Adolescent Psychiatry, vol. 32, no. 5, pp. 1032-7, Sep. 1993.
145. S. Deb, K. B. Prasad, H. Seth, and J. M. Eagles, "A comparison of obstetric and neonatal complications between children with autistic disorder and their siblings.," Journal of intellectual disability research, vol. 41 ( Pt 1), pp. 81-86, 1997.
146. S. Milberger, J. Biederman, S. V. Faraone, J. Guite, and M. T. Tsuang, "Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: issues of gene-environment interaction.," Biological psychiatry, vol. 41, no. 1, pp. 65-75, Jan. 1997.
147. S. Cnattingius, C. M. Hultman, M. Dahl, and P. Sparén, "Very preterm birth, birth trauma, and the risk of anorexia nervosa among girls.," Archives of general psychiatry, vol. 56, no. 7, pp. 634-8, Jul. 1999.
148. D. L. Foley, L. R. Thacker, S. H. Aggen, M. C. Neale, and K. S. Kendler, "Pregnancy and perinatal complications associated with risks for common psychiatric disorders in a population-based sample of female twins.," American Journal of Medical Genetics, vol. 105, no. 5, pp. 426-431, 2001.
149. A. S. Brown, J. van Os, C. Driessens, H. W. Hoek, and E. S. Susser, "Further Evidence of Relation Between Prenatal Famine and Major Affective Disorder," American Journal of Psychiatry, vol. 157, no. 2, pp. 190-195, Feb. 2000.
150. H. Verdoux and A.-L. Sutter, "Perinatal risk factors for schizophrenia: diagnostic specificity and relationships with maternal psychopathology.," American journal of medical genetics, vol. 114, no. 8, pp. 898-905, Dec. 2002.
151. H. Verdoux, "Perinatal risk factors for schizophrenia: how specific are they?," Current psychiatry reports, vol. 6, no. 3, pp. 162-7, Jun. 2004.
152. A. V. Jablensky, V. Morgan, S. R. Zubrick, C. Bower, and L.-anne Yellachich, "Pregnancy, delivery, and neonatal complications in a Population Cohort of Women With Schizophrenia and Major Affective Disorders," American journal of psychiatry, vol. 162, pp. 79-91, 2005.
153. K. Narita et al., "Human leukocyte antigen and season of birth in Japanese patients with schizophrenia.," The American journal of psychiatry, vol. 157, no. 7, pp. 1173-5, Jul. 2000.
154. M. Tochigi et al., "Human leukocyte antigen-A specificities and its relation with season of birth in Japanese patients with schizophrenia," Neuroscience Letters, vol. 329, no. 2, pp. 201-204, Aug. 2002.
155. J. Chotai, A. Serretti, E. Lattuada, C. Lorenzi, and R. Lilli, "Gene-environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms.," Psychiatry research, vol. 119, no. 1-2, pp. 99-111, Jul. 2003.
156. J.-W. Muntjewerff, R. a Ophoff, J. E. Buizer-Voskamp, E. Strengman, and M. den Heijer, "Effects of season of birth and a common MTHFR gene variant on the risk of schizophrenia.," European neuropsychopharmacology, vol. 21, no. 4, pp. 300-5, Apr. 2011.
157. R. Schmidt-Kastner, J. van Os, H. W M Steinbusch, and C. Schmitz, "Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia.," Schizophrenia research, vol. 84, no. 2-3, pp. 253-71, Jun. 2006.
158. B. Abazyan et al., "Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology.," Biological psychiatry, vol. 68, no. 12, pp. 1172-81, Dec. 2010.
159. J. T. Manning, S. Baron-Cohen, S. Wheelwright, and G. Sanders, "The 2nd to 4th digit ratio and autism.," Developmental medicine and child neurology, vol. 43, no. 3, pp. 160-4, Mar. 2001.
160. C. Casar, M. Artamendi, M. Gutiérrez, P. Gil, M. J. García, and M. J. Cuesta, "[Neuropsychological deficits, obstetric complications and premorbid adjustment in patients with the first psychotic episode].," Actas luso-españolas de neurología, psiquiatría y ciencias afines, vol. 25, no. 5, pp. 303-7.
161. A. Lane et al., "Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors.," Psychiatry research, vol. 64, no. 2, pp. 105-14, Sep. 1996.
162. M. Hadders-Algra, H. J. Huisjes, and B. C. Touwen, "Perinatal risk factors and minor neurological dysfunction: significance for behaviour and school achievement at nine years.," Developmental Medicine and Child Neurology, vol. 30, no. 4, pp. 482-491, 1988.
163. E. O'Callaghan et al., "Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study.," British Medical Journal, vol. 305, no. 6864, pp. 1256-9, Nov. 1992.
164. I. M. Rosso, T. D. Cannon, T. Huttunen, M. O. Huttunen, J. Lönnqvist, and T. L. Gasperoni, "Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort.," The American journal of psychiatry, vol. 157, no. 5, pp. 801-7, May. 2000.
165. A. Hoff and W. Kremen, "Sex differences in neurocognitive function in schizophrenia," in Psychiatric illness in women: emerging treatments and research, F. Lewis-Hall, T. S. Williams, J. A. Panetta, and J. H. Herrera, Eds. Washington, D.C.: American Psychiatric Publishing, 2002, pp. 215-238.
166. M. J. Khoury, J. S. Marks, B. J. McCarthy, and S. M. Zaro, "Factors affecting the sex differential in neonatal mortality: the role of respiratory distress syndrome.," American journal of obstetrics and gynecology, vol. 151, no. 6, pp. 777-82, Mar. 1985.
167. A. Foerster, S. W. Lewis, M. J. Owen, and R. M. Murray, "Low birth weight and a family history of schizophrenia predict poor premorbid functioning in psychosis," Schizophrenia Research, vol. 5, no. 1, pp. 13-20, Jul. 1991.
168. H. Matsumoto, N. Takei, F. Saito, K. Kachi, and N. Mori, "The association between obstetric complications and childhood-onset schizophrenia: a replication study.," Psychological Medicine, vol. 31, no. 5, pp. 907-914, 2001.
169. G. A. Light and D. L. Braff, "Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia.," The American journal of psychiatry, vol. 162, no. 9, pp. 1741-3, Sep. 2005.
170. D. C. Javitt, A. Shelley, and W. Ritter, "Associated deficits in mismatch negativity generation and tone matching in schizophrenia.," Clinical neurophysiology, vol. 111, no. 10, pp. 1733-7, Oct. 2000.
171. R. E. Hoffman, J. Rapaport, C. M. Mazure, and D. M. Quinlan, "Selective speech perception alterations in schizophrenic patients reporting hallucinated 'voices'," American Journal of Psychiatry, vol. 156, no. 3, pp. 393-399, 1999.
172. R. A. Adcock et al., "When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1132-41, Nov. 2009.
173. B. F. O'Donnell et al., "Identification of neural circuits underlying P300 abnormalities in schizophrenia," Psychophysiology, vol. 36, no. 3, pp. 388-398, Aug. 1999.
174. S. Bender, M. Weisbrod, and F. Resch, "Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?," Journal of neural transmission, vol. 114, no. 9, pp. 1199-215, Sep. 2007.
175. M. E. Shenton, C. C. Dickey, M. Frumin, and R. W. McCarley, "A review of MRI findings in schizophrenia.," Schizophrenia research, vol. 49, no. 1-2, pp. 1-52, Apr. 2001.
176. J. Sun, J. J. Maller, L. Guo, and P. B. Fitzgerald, "Superior temporal gyrus volume change in schizophrenia: a review on region of interest volumetric studies.," Brain research reviews, vol. 61, no. 1, pp. 14-32, Jun. 2009.
177. R. A. Sweet, S. E. Bergen, Z. Sun, M. J. Marcsisin, A. R. Sampson, and D. a Lewis, "Anatomical evidence of impaired feedforward auditory processing in schizophrenia.," Biological psychiatry, vol. 61, no. 7, pp. 854-64, Apr. 2007.
178. D. C. Javitt, M. Steinschneider, C. E. Schroeder, and J. C. Arezzo, "Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.," Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 11962-7, Oct. 1996.
179. M. I. Garrido, J. M. Kilner, K. E. Stephan, and K. J. Friston, "Clinical Neurophysiology The mismatch negativity: A review of underlying mechanisms," Clinical Neurophysiology, vol. 120, no. 3, pp. 453-463, 2009.
180. J. S. Butler, S. Molholm, I. C. Fiebelkorn, M. R. Mercier, T. H. Schwartz, and J. J. Foxe, "Common or redundant neural circuits for duration processing across audition and touch.," The Journal of neuroscience, vol. 31, no. 9, pp. 3400-6, Mar. 2011.
181. T. Baldeweg, A. Klugman, J. Gruzelier, and S. R. Hirsch, "Mismatch negativity potentials and cognitive impairment in schizophrenia," Schizophrenia Research, vol. 69, no. 2-3, pp. 203-217, Aug. 2004.
182. C. A. Brenner et al., "Steady state responses: electrophysiological assessment of sensory function in schizophrenia.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1065-77, Nov. 2009.
183. A. J. Fallgatter et al., "DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals.," Neuropsychopharmacology, vol. 31, no. 9, pp. 2002-10, Sep. 2006.
184. F. Jessen et al., "Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia.," Neuroscience letters, vol. 309, no. 3, pp. 185-8, Aug. 2001.
185. P. T. Michie, H. Innes-Brown, J. Todd, and A. V. Jablensky, "Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders.," Biological psychiatry, vol. 52, no. 7, pp. 749-58, Oct. 2002.
186. E. Bramon, "Mismatch negativity in schizophrenia: a family study," Schizophrenia Research, vol. 67, no. 1, pp. 1-10, Mar. 2004.
187. K. Baker, T. Baldeweg, S. Sivagnanasundaram, P. Scambler, and D. Skuse, "COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.," Biological psychiatry, vol. 58, no. 1, pp. 23-31, Jul. 2005.
188. J. S. Kwon et al., "Gamma frequency-range abnormalities to auditory stimulation in schizophrenia.," Archives of general psychiatry, vol. 56, no. 11, pp. 1001-5, Nov. 1999.
189. L. E. Hong et al., "Evoked gamma band synchronization and the liability for schizophrenia.," Schizophrenia research, vol. 70, no. 2-3, pp. 293-302, Oct. 2004.
190. C. A. Brenner, O. Sporns, P. H. Lysaker, and B. F. O'Donnell, "EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder.," The American journal of psychiatry, vol. 160, no. 12, pp. 2238-40, Dec. 2003.
191. P. D. Butler, S. M. Silverstein, and S. C. Dakin, "Visual perception and its impairment in schizophrenia.," Biological psychiatry, vol. 64, no. 1, pp. 40-7, Jul. 2008.
192. J. T. Kantrowitz, P. D. Butler, I. Schecter, G. Silipo, and D. C. Javitt, "Seeing the world dimly: the impact of early visual deficits on visual experience in schizophrenia.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1085-94, Dec. 2009.
193. C. G. Kohler, J. B. Walker, E. a Martin, K. M. Healey, and P. J. Moberg, "Facial emotion perception in schizophrenia: a meta-analytic review.," Schizophrenia bulletin, vol. 36, no. 5, pp. 1009-19, Sep. 2010.
194. P. D. Butler et al., "Sensory contributions to impaired emotion processing in schizophrenia.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1095-107, Nov. 2009.
195. J. Brekke, D. D. Kay, K. S. Lee, and M. F. Green, "Biosocial pathways to functional outcome in schizophrenia.," Schizophrenia research, vol. 80, no. 2-3, pp. 213-25, Dec. 2005.
196. P. J. Uhlhaas, W. A. Phillips, and S. M. Silverstein, "The course and clinical correlates of dysfunctions in visual perceptual organization in schizophrenia during the remission of psychotic symptoms.," Schizophrenia research, vol. 75, no. 2-3, pp. 183-92, Jun. 2005.
197. S. M. Silverstein, R. A. Knight, S. B. Schwarzkopf, L. L. West, L. M. Osborn, and D. Kamin, "Stimulus configuration and context effects in perceptual organization in schizophrenia," Journal of abnormal psychology, vol. 105, no. 3, pp. 410-420, 1996.
198. W. A. Phillips and S. M. Silverstein, "Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia.," The Behavioral and brain sciences, vol. 26, no. 1, pp. 65-82; discussion 82-137, Feb. 2003.
199. J. H. Yoon et al., "Diminished orientation-specific surround suppression of visual processing in schizophrenia.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1078-84, Nov. 2009.
200. M. J. Coleman et al., "Schizophrenia patients show deficits in shifts of attention to different levels of global-local stimuli: evidence for magnocellular dysfunction.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1108-16, Nov. 2009.
201. P. D. Butler et al., "Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments.," Brain: a journal of neurology, vol. 130, no. 2, pp. 417-30, Feb. 2007.
202. A. D. Nguyen, M. E. Shenton, and J. J. Levitt, "Olfactory Dysfunction in Schizophrenia: A Review of Neuroanatomy and Psychophysiological Measurements," Harvard review of psychiatry, vol. 18, no. 5, pp. 279-292, 2010.
203. L. B. Buck, "Smell and taste: The chemical senses," in Principles of Neural Science, 4th ed., E. R. Kandel, J. H. Schwartz, and T. M. Jessell, Eds. New York: McGraw-Hill, 2000, pp. 625-647.
204. B. I. Turetsky, C.-G. Hahn, K. Borgmann-Winter, and P. J. Moberg, "Scents and nonsense: olfactory dysfunction in schizophrenia.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1117-31, Nov. 2009.
205. F. Féron, C. Perry, M. H. Hirning, J. McGrath, and A. Mackay-Sim, "Altered adhesion, proliferation and death in neural cultures from adults with schizophrenia.," Schizophrenia research, vol. 40, no. 3, pp. 211-8, Dec. 1999.
206. D. Malaspina and E. Coleman, "Olfaction and social drive in schizophrenia.," Archives of general psychiatry, vol. 60, no. 6, pp. 578-84, Jun. 2003.
207. C. Corcoran et al., "Olfactory deficits, cognition and negative symptoms in early onset psychosis.," Schizophrenia research, vol. 80, no. 2-3, pp. 283-93, Dec. 2005.
208. H. Blumenfeld, Neuroanatomy Through Clinical Cases. Sunderland: Sinauer Associates, Inc., 2002, p. 951.
209. B. P. Chang and M. F. Lenzenweger, "Somatosensory processing and schizophrenia liability: proprioception, exteroceptive sensitivity, and graphesthesia performance in the biological relatives of schizophrenia patients.," Journal of abnormal psychology, vol. 114, no. 1, pp. 85-95, Feb. 2005.
210. M. F. Lenzenweger, "Two-point discrimination thresholds and schizotypy: illuminating a somatosensory dysfunction.," Schizophrenia research, vol. 42, no. 2, pp. 111-24, Apr. 2000.
211. R. M. Bauer and J. A. Demery, "Agnosia," in Clinical Neuropsychology, 4th ed., K. M. Heilman and E. Valenstein, Eds. New York: Oxford University Press, 2003, p. 716.
212. M.-X. Huang et al., "Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task.," Brain topography, vol. 23, no. 1, pp. 82-104, Mar. 2010.
213. C. Norra et al., "High-frequency somatosensory thalamocortical oscillations and psychopathology in schizophrenia.," Neuropsychobiology, vol. 49, no. 2, pp. 71-80, Jan. 2004.
214. M. Reite, P. Teale, T. L. Benkers, and J. Carlson, "in Schizophrenia," Psychiatry: Interpersonal and Biological Processes, no. December, pp. 2148-2153, 2003.
215. S. Knecht, E. Kunesch, and a Schnitzler, "Parallel and serial processing of haptic information in man: effects of parietal lesions on sensorimotor hand function.," Neuropsychologia, vol. 34, no. 7, pp. 669-87, Jul. 1996.
216. B. P. Chang and M. F. Lenzenweger, "Somatosensory processing in the biological relatives of schizophrenia patients: A signal detection analysis of two-point discrimination.," Journal of Abnormal Psychology, vol. 110, no. 3, pp. 433-442, 2001.
217. B. P. Chang and M. F. Lenzenweger, "Investigating graphesthesia task performance in the biological relatives of schizophrenia patients.," Schizophrenia bulletin, vol. 30, no. 2, pp. 327-34, Jan. 2004.
218. D. C. Javitt, E. Liederman, A. Cienfuegos, and A. M. Shelley, "Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia.," Schizophrenia bulletin, vol. 25, no. 4, pp. 763-75, Jan. 1999.
219. D. C. Javitt, "Sensory processing in schizophrenia: neither simple nor intact.," Schizophrenia bulletin, vol. 35, no. 6, pp. 1059-64, Nov. 2009.
220. L. Kopala, C. Clark, and T. A. Hurwitz, "Sex differences in olfactory function in schizophrenia," American Journal of Psychiatry, vol. 146, no. 10, pp. 1320-1322, Oct. 1989.
221. P. J. Moberg et al., "Impairment of Odor Hedonics in Men With Schizophrenia," American Journal of Psychiatry, vol. 160, no. 10, pp. 1784-9, Jan. 2003.
222. K. P. Good, R. A. Leslie, J. McGlone, H. I. Milliken, and L. C. Kopala, "Sex differences in olfactory function in young patients with psychotic disorders.," Schizophrenia research, vol. 97, no. 1-3, pp. 97-102, Dec. 2007.
223. V. Kumari, "Sex differences and hormonal influences in human sensorimotor gating: implications for schizophrenia.," Current topics in behavioral neurosciences, vol. 8, pp. 141-54, Jan. 2011.
224. D. Braff, C. Stone, E. Callaway, M. Geyer, I. Glick, and L. Bali, "Prestimulus effects on human startle reflex in normals and schizophrenics.," Psychophysiology, vol. 15, no. 4, pp. 339-43, Jul. 1978.
225. L. A. Gottschalk, J. L. Haer, and D. E. Bates, "Effect of sensory overload on psychological state. Changes in social alienation-personal disorganization and cognitive-intellectual impairment.," Archives of general psychiatry, vol. 27, no. 4, pp. 451-7, Oct. 1972.
226. D. L. Braff and M. A. Geyer, "Sensorimotor gating and schizophrenia. Human and animal model studies.," Archives of general psychiatry, vol. 47, no. 2, pp. 181-8, Feb. 1990.
227. W. Hasenkamp et al., "Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.," Psychiatry research, vol. 178, no. 2, pp. 236-43, Jul. 2010.
228. V. Kumari, E. Antonova, and M. A. Geyer, "Prepulse inhibition and 'psychosis-proneness' in healthy individuals: an fMRI study.," European psychiatry, vol. 23, no. 4, pp. 274-80, Jul. 2008.
229. K. S. Cadenhead, N. R. Swerdlow, K. M. Shafer, M. Diaz, and D. L. Braff, "Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits.," The American journal of psychiatry, vol. 157, no. 10, pp. 1660-8, Oct. 2000.
230. N. Petrovsky et al., "Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers.," Neuropsychopharmacology, vol. 35, no. 7, pp. 1429-39, Jun. 2010.
231. V. Kumari, E. Antonova, M. A. Geyer, D. Ffytche, S. C. R. Williams, and T. Sharma, "A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics.," The international journal of neuropsycho-pharmacology, vol. 10, no. 4, pp. 463-77, Aug. 2007.
232. V. Kumari et al., "Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women.," Neuropsychopharmacology, vol. 35, no. 4, pp. 929-37, Mar. 2010.
233. E. Walker and D. J. Walder, "Neurohormonal aspects of the development of psychotic disorders," in Neurodevelopmental mechanisms in psychopathology, D. Cichetti and E. Walker, Eds. Boston, MA: Cambridge University Press, 2002, pp. 526-544.
234. E. Walker, Z. Sabuwalla, A. Bollini, and D. Walder, "Gender and stress," in Women's mental health: a life-cycle approach, S. Roman and M. Seeman, Eds. New York, NY: Lippincott, Williams and Wilkins, 2005, pp. 35-47.